Inspira Technologies Oxy BHN (IINN)
NASDAQ:IINN
Want to see IINN full AI Analyst Report?
IINN Stock Chart & Stats
$0.96
-$0.05(-4.95%)
At close: 4:00 PM EST
$0.96
-$0.05(-4.95%)
Day’s Range― - ―
52-Week Range$0.34 - $1.65
Previous CloseN/A
Volume61.41K
Average Volume (3M)330.47K
Market Cap
$18.91M
Enterprise Value$7.77M
Total Cash (Recent Filing)$2.13M
Total Debt (Recent Filing)$640.00K
Price to Earnings (P/E)―
Beta2.08
Next Earnings
Aug 06, 2026EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding43,579,260
10 Day Avg. Volume227,613
30 Day Avg. Volume330,466
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)11.48
Price to Sales (P/S)92.25
P/FCF Ratio-2.68
Enterprise Value/Market Cap0.41
Enterprise Value/Revenue26.89
Enterprise Value/Gross Profit3.89K
Enterprise Value/Ebitda-1.08
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.11
Revenue Forecast (FY)$48.00M
Bulls Say, Bears Say
Bulls Say
Acquisition Of Nano Dimension AME PlatformAcquiring Nano Dimension’s AME platform gives Inspira immediate IP, equipment, customer contracts and operational capability in advanced 3D electronic printing. This materially diversifies revenue channels toward high-value quantum and defense markets and creates durable consumables/service revenue potential tied to installed systems.
Large Commercial Validation And Market AccessVendor approval from Clalit provides institutional validation and immediate procurement pathways across a very large integrated health system. That structural channel can support multi-hospital deployments, standardized procurement cycles and recurring consumables/service orders, strengthening a durable commercial base for the ART100 system.
Experienced Commercial Leader AddedHiring an executive with proven experience scaling customer success and commercial operations in advanced AME businesses strengthens go-to-market execution. This bolsters ability to integrate acquired AME assets, convert reference sites into recurring revenue, and professionalize sales and service functions over the medium term.
Bears Say
Persistent Negative Cash FlowSustained annual operating and free cash flow deficits indicate structural cash burn that requires repeated external financing. This undermines financial flexibility, forces dilution or debt reliance, and constrains investment in commercialization, regulatory work, and scaling until positive cash generation is achieved.
Eroding Equity And Weak ProfitabilityMaterial declines in equity combined with persistent operating losses mean the balance sheet cushion is shrinking. Negative returns on equity and continued losses reduce capacity to absorb setbacks, limit borrowing headroom, and increase the probability that further capital raises will be required under adverse terms.
Nasdaq Listing Compliance RiskActive Nasdaq deficiency notices for market-value and minimum bid requirements create durable execution risk: potential delisting would impair access to U.S. capital markets, hinder strategic partnerships, and complicate fundraising and customer confidence until compliance is restored.
Inspira Technologies Oxy BHN News
IINN FAQ
What was Inspira Technologies Oxy BHN’s price range in the past 12 months?
Inspira Technologies Oxy BHN lowest stock price was $0.34 and its highest was $1.65 in the past 12 months.
What is Inspira Technologies Oxy BHN’s market cap?
Inspira Technologies Oxy BHN’s market cap is $18.91M.
When is Inspira Technologies Oxy BHN’s upcoming earnings report date?
Inspira Technologies Oxy BHN’s upcoming earnings report date is Aug 06, 2026 which is in 88 days.
How were Inspira Technologies Oxy BHN’s earnings last quarter?
Inspira Technologies Oxy BHN released its earnings results on Mar 26, 2026. The company reported -$0.21 earnings per share for the quarter, missing the consensus estimate of -$0.2 by -$0.01.
Is Inspira Technologies Oxy BHN overvalued?
According to Wall Street analysts Inspira Technologies Oxy BHN’s price is currently Overvalued.
Does Inspira Technologies Oxy BHN pay dividends?
Inspira Technologies Oxy BHN does not currently pay dividends.
What is Inspira Technologies Oxy BHN’s EPS estimate?
Inspira Technologies Oxy BHN’s EPS estimate is -0.03.
How many shares outstanding does Inspira Technologies Oxy BHN have?
Inspira Technologies Oxy BHN has 43,579,260 shares outstanding.
What happened to Inspira Technologies Oxy BHN’s price movement after its last earnings report?
Inspira Technologies Oxy BHN reported an EPS of -$0.21 in its last earnings report, missing expectations of -$0.2. Following the earnings report the stock price went down -23.092%.
Which hedge fund is a major shareholder of Inspira Technologies Oxy BHN?
Currently, no hedge funds are holding shares in IINN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Inspira Technologies Oxy BHN
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.
Technical Analysis
Ownership Overview
―
Insiders
<0.01% Mutual Funds
0.02% Other Institutional Investors
99.98% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---